Results

• All
• Video
• Audio
• Images

• Most recent

1–1 of 1 result for novel mechanism of action

• 

  ENVISION Trial 24-Week Data: Phase 2 Study of UBX1325, a New Senolytic Agent for Patients With Wet AMD

  Raj K. Maturi, MD

  Annual Meeting Talks

  2023